
- Telehealth Visits
- Insurances Accepted

Chiara Corbetta-Rastelli, MD
She | Her | HersObstetrics and Gynecology- Telehealth Visits
- Insurances Accepted



Chiara Corbetta-Rastelli, MD
She | Her | HersObstetrics and Gynecology- Telehealth Visits
- Insurances Accepted
On this page
About me
Dr. Chiara Corbetta-Rastelli is a maternal-fetal medicine specialist who cares for patients experiencing high-risk pregnancies. She has special interests in caring for patients with diabetes during pregnancy, neurological disorders, vasa previa (a complication where umbilical or placental blood vessels run near the opening of the cervix), placenta accreta spectrum disorder (when the placenta incorrectly attaches to the uterine muscle) and helping patients with complex conditions navigate family planning.
Corbetta-Rastelli earned her medical degree from UCSF, where she also completed a residency in obstetrics and gynecology and a fellowship in maternal-fetal medicine.
Education
Board Certification
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Residency
- Obstetrics & Gynecology, UCSF School of Medicine -GME
Internship
- Obstetrics & Gynecology, UCSF School of Medicine -GME
School
- MD, UCSF School of Medicine
Academic Title
- Assistant Professor
Care Keywords
Services
- Obstetrics and Gynecology
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223429%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223429%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.